secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000009326-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem Q2 2025: record net sales $255.5M, adj. EPS $1.27 beat
--------------------------------------------------------------

- Net sales $255.5M, +9.1% YoY; GAAP EPS $1.17 vs $0.98 prior year quarter.
- Record adjusted EBITDA $69.2M (+11.2%); adjusted EPS $1.27 vs $1.09.
- All three segments grew; record sales and earnings in Human Nutrition & Health and Specialty Products.
- Plans new $36M micro-encapsulation facility in Orange County, NY, pending county approval.
- EU imposes provisional anti-dumping duties of 95.4%-120.8% on Chinese choline chloride imports effective July 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000000932625000012/0000009326-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000000932625000012/bcpc-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000009326-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer